Lav Leads $19M Series B Funding In Novlead Biotech
PRIVATENov 18, 2021
Amount Raised
$19 Million
Round Type
Series B
Description
Medical devices maker Novlead Biotech announced on Tuesday that it has garnered 120 million yuan ($19 million) in a Series B round of financing led by the biomedical-focussed venture capital firm Lilly Asia Ventures (LAV).
Who to call at Novlead Biotech, and when
A new round usually means Novlead Biotech is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Novlead Biotech raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Novlead Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novlead Biotech. With Fundz connected, it knows.